Raythera

Acquired

Innovating Breakthrough Therapies for Unmet Medical Needs

San Diego, United States · Founded 2023 · $110.0M raised

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$110.0M
Last Round
$110.0M Series AApr 2025
Rounds
1
Acquired by
BiogenAug 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

RayThera is a San Diego-based biotechnology company founded in 2023, focused on discovering and developing small molecule therapies for critical unmet needs in immunology. Backed by Foresite Capital, OrbiMed, and TTM Capital, the company combines decades of drug discovery expertise with an agile approach to accelerate development of transformative immunology treatments.

Summary

Raythera is a Biotech company based in San Diego, United States, founded in 2023. It has raised $110.0M in total across 1 round, most recently a $110.0M Series A round in Apr 2025. Investors include Foresite Capital, OrbiMed and TTM Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionAug 2026

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Raythera on Indexed.vc
<a href="https://indexed.vc/companies/raythera"><img src="https://indexed.vc/api/badge/company/raythera" alt="Raythera on Indexed.vc" width="260" height="76" /></a>